RBC
Ronald Blue & Co Portfolio holdings
AUM
$3.1B
This Quarter Return
+3.84%
1 Year Return
+12.82%
3 Year Return
+2.42%
5 Year Return
–
10 Year Return
–
AUM
$1.57B
AUM Growth
+$1.57B
(+15%)
Cap. Flow
+$157M
Cap. Flow
% of AUM
9.94%
Top 10 Holdings %
Top 10 Hldgs %
84.02%
Holding
361
New
29
Increased
186
Reduced
100
Closed
20
Top Buys
| 1 |
Vident US Equity Strategy ETF
VUSE
|
$114M |
| 2 |
Vident International Equity Strategy
VIDI
|
$21.6M |
| 3 |
iShares Gold Trust
IAU
|
$10.3M |
| 4 |
Apple
AAPL
|
$4.25M |
| 5 |
iShares MSCI ACWI ex US ETF
ACWX
|
$2.61M |
Top Sells
| 1 |
iShares MSCI ACWI ETF
ACWI
|
$3.75M |
| 2 |
iShares Floating Rate Bond ETF
FLOT
|
$3.34M |
| 3 |
iShares TIPS Bond ETF
TIP
|
$2.46M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
$928K |
| 5 |
AstraZeneca
AZN
|
$923K |
Sector Composition
| 1 | Healthcare | 2.52% |
| 2 | Financials | 2.33% |
| 3 | Energy | 2.1% |
| 4 | Industrials | 1.95% |
| 5 | Consumer Staples | 1.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Vident International Equity Strategy
VIDI
$382M
| $717M | 45.53% |
27,986,115
+844,685
| +3% | +$21.6M |
|
|
2
iShares Gold Trust
IAU
$50.6B
| $255M | 16.19% |
19,800,843
+800,358
| +4% | +$10.3M |
|
|
3
Vident US Equity Strategy ETF
VUSE
$630M
| $164M | 10.42% |
6,186,712
+4,302,497
| +228% | +$114M |
|
|
4
iShares MSCI ACWI ex US ETF
ACWX
$6.63B
| $75.7M | 4.8% |
1,575,414
+54,407
| +4% | +$2.61M |
|
5
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$4.59B
| $45.6M | 2.9% |
759,475
+16,920
| +2% | +$1.02M |
|
|
6
iShares MSCI ACWI ETF
ACWI
$22B
| $34.7M | 2.21% |
576,603
-62,204
| -10% | -$3.75M |
|
7
Exxon Mobil
XOM
$487B
| $11.3M | 0.72% |
112,058
-2,554
| -2% | -$257K |
|
8
HCA Healthcare
HCA
$94.5B
| $7.74M | 0.49% |
137,330
| – | – |
|
9
Cullen/Frost Bankers
CFR
$8.3B
| $6.38M | 0.41% |
80,387
+296
| +0.4% | +$23.5K |
|
10
Procter & Gamble
PG
$368B
| $5.59M | 0.35% |
71,073
-730
| -1% | -$57.4K |
|
|
11
Apple
AAPL
$3.45T
| $4.93M | 0.31% |
53,010
+45,749
| +630% | +$4.25M |
|
|
LPNT
12
DELISTED
LifePoint Health, Inc.
LPNT
| $4.79M | 0.3% |
77,191
| – | – |
|
13
Eli Lilly
LLY
$657B
| $4.74M | 0.3% |
76,230
+59
| +0.1% | +$3.67K |
|
14
iShares MSCI EAFE ETF
EFA
$66B
| $4.29M | 0.27% |
62,733
+6,569
| +12% | +$449K |
|
15
Coca-Cola
KO
$297B
| $4.22M | 0.27% |
99,488
+963
| +1% | +$40.8K |
|
16
Chevron
CVX
$324B
| $4.21M | 0.27% |
32,220
+1,206
| +4% | +$157K |
|
17
Verizon
VZ
$186B
| $3.97M | 0.25% |
81,124
+5,374
| +7% | +$263K |
|
18
iShares MSCI Emerging Markets ETF
EEM
$19B
| $3.23M | 0.2% |
74,606
+49,045
| +192% | +$2.12M |
|
19
Dover
DOV
$24.5B
| $3.22M | 0.2% |
35,386
+1
| +0% | +$91 |
|
20
AT&T
T
$209B
| $3.17M | 0.2% |
89,734
+4,785
| +6% | +$169K |
|
21
iShares Core S&P 500 ETF
IVV
$662B
| $3.09M | 0.2% |
15,689
-1,277
| -8% | -$252K |
|
22
IBM
IBM
$227B
| $3.05M | 0.19% |
16,810
+290
| +2% | +$52.6K |
|
23
Mondelez International
MDLZ
$79.5B
| $2.9M | 0.18% |
77,195
+383
| +0.5% | +$14.4K |
|
24
Pfizer
PFE
$141B
| $2.87M | 0.18% |
96,537
+9,335
| +11% | +$277K |
|
25
Johnson & Johnson
JNJ
$427B
| $2.62M | 0.17% |
25,071
-49
| -0.2% | -$5.13K |
|